Rituximab Dosing in Glomerular Diseases: A Scoping Review.

ABSTRACT:

Purpose of review

Rituximab is increasingly prescribed for glomerular diseases. However, the recently published Kidney Disease Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline for the Management of Glomerular Diseases lacks details on recommended dosing regimens for most individual glomerular diseases. We performed this scoping review summarizing the evidence for rituximab dosing in glomerular disease.

Sources of information

PubMed database.

Methods

The PubMed search methodology was developed with a medical librarian and performed by the first, with review by a second, author. Randomized controlled trials (RCTs) and prospective cohort studies (PCSs) examining rituximab efficacy and/or safety in antineutrophil cytoplasm antibody (ANCA)-associated vasc

SUBMITTER: Alzayer H 

PROVIDER: S-EPMC9583230 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature